---
title: "Novanta Expands Credit Facilities with New Term Loan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286622699.md"
description: "Novanta Inc. has amended its credit agreement to include $200 million in delayed draw term loan commitments, enhancing financial flexibility. The loans mature on June 27, 2030, with quarterly amortization starting in Q3 2026. Analysts rate NOVT stock as a Buy with a $173.00 price target, citing strong technical momentum and a solid financial foundation, despite high valuation concerns."
datetime: "2026-05-15T22:56:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286622699.md)
  - [en](https://longbridge.com/en/news/286622699.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286622699.md)
---

# Novanta Expands Credit Facilities with New Term Loan

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Novanta ( (NOVT) ) has shared an update.

On May 15, 2026, Novanta Inc. and several of its subsidiaries amended their existing credit agreement to add $200 million in delayed draw term loan commitments, available for up to six months after that date and maturing on June 27, 2030. The loans, which carry interest tied to base or benchmark rates plus a margin based on Novanta’s leverage ratio and amortize quarterly beginning in the third quarter of 2026, are expected to enhance the company’s financial flexibility, while the amendment also resets the capacity for additional term loan and revolving credit commitments from the new effective date, potentially expanding future borrowing headroom for the group.

The most recent analyst rating on (NOVT) stock is a Buy with a $173.00 price target. To see the full list of analyst forecasts on Novanta stock, see the NOVT Stock Forecast page.

**Spark’s Take on NOVT Stock**

According to Spark, TipRanks’ AI Analyst, NOVT is a Outperform.

NOVT scores well overall on strong technical momentum and a solid (improving) financial foundation led by a strengthened balance sheet, supported by a constructive earnings outlook and strong bookings. The main offset is valuation, with a high P/E and no dividend yield provided, plus some margin and timing risks noted on the earnings call.

To see Spark’s full report on NOVT stock, click here.

**More about Novanta**

Novanta Inc. is a diversified industrial technology company that, through its subsidiaries in the U.S., U.K. and Europe, utilizes syndicated credit facilities to support its global operations and financing needs. Its capital structure relies on term loans and revolving commitments arranged with a consortium of bank lenders to fund growth and manage liquidity across multiple jurisdictions.

**Average Trading Volume:** 426,796

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** $5.55B

Learn more about NOVT stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [NOVT.US](https://longbridge.com/en/quote/NOVT.US.md)
- [NOVTU.US](https://longbridge.com/en/quote/NOVTU.US.md)

## Related News & Research

- [Novanta Inc. $NOVT Position Boosted by Truist Financial Corp](https://longbridge.com/en/news/286643784.md)
- [Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026 | NOVT Stock News](https://longbridge.com/en/news/286611112.md)
- [11:52 ETNavanta Named a 2026 USA TODAY Top Workplace](https://longbridge.com/en/news/286128940.md)
- [Does Novanta’s (NOVT) Insider Sales and Earnings Setup Clarify or Cloud Its Growth Narrative?](https://longbridge.com/en/news/286004021.md)
- [Sotera Health reprices term loans with $1.42 billion refinancing amendment](https://longbridge.com/en/news/287112579.md)